SCHEMBL403390

SCHEMBL403390

COC(=O)c1ccc(-c2nc(C)ccc2C(=O)Nc2ccc(CCCC(=O)O)cc2C(=O)N(C)C)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.37
NTRK1 P04629 1/20 0.36
NTRK2 Q16620 1/20 0.36
KDM4E B2RXH2 2/20 0.36
HPGD P15428 2/20 0.36
ALDH1A1 P00352 1/20 0.36
HSD17B10 Q99714 1/20 0.36
PLK1 P53350 5/20 0.35
PLK3 Q9H4B4 2/20 0.35
GAA P10253 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
NR1H4 Q96RI1 2/20 0.34
PPARA Q07869 2/20 0.34
SORT1 Q99523 1/20 0.34
CYP4A11 Q02928 2/20 0.34
RAB9A P51151 1/20 0.34
PPARG P37231 1/20 0.34
TP53 P04637 1/20 0.34
PRSS12 P56730 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5319289 0.90 KDM4E (0.45) KCNH2KDM4EHPGDALDH1A1HSD17B10
SCHEMBL5318151 0.90 SORT1 (0.39) NTRK1NTRK2MEN1KMT2ANR1H4
SCHEMBL403406 0.86 KCNH2 (0.34) KCNH2NTRK1NTRK2KDM4EHPGD
SCHEMBL5319572 0.85 KCNH2 (0.35) KCNH2NTRK1NTRK2KDM4EHPGD
SCHEMBL403307 0.84 KCNH2 (0.36) KCNH2KDM4EHPGDALDH1A1MEN1
SCHEMBL403620 0.82 NTRK1 (0.41) KCNH2NTRK1NTRK2KDM4EALDH1A1
SCHEMBL403346 0.82 NTRK1 (0.42) KCNH2NTRK1NTRK2PLK1NR1H4
SCHEMBL400298 0.81 NTRK1 (0.41) KCNH2NTRK1NTRK2PLK1MEN1
SCHEMBL402750 0.80 NTRK1 (0.40) KCNH2NTRK1NTRK2KDM4EHPGD
SCHEMBL5318000 0.80 NTRK1 (0.43) KCNH2NTRK1NTRK2PLK1PLK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
EP-1803452-A1 ESTER DERIVATIVE AND PHARMACEUTICAL USE THEREOF Japan Tobacco, Inc. (JP) 2007-07-04 EP disclosed
US-20060089392-A1 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089392-A1 Ester derivatives and medicinal use thereof MTTP, CETP, LIPA KCNH2 4171/4885NTRK1 3420/4885NTRK2 2775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.